awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35020443-8A23E90D-8084-493A-BB4D-114C0612B316
Q35020443-8A23E90D-8084-493A-BB4D-114C0612B316
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35020443-8A23E90D-8084-493A-BB4D-114C0612B316
Breakthrough cancer medicine and its impact on novel drug development in China: report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting.
P2860
Q35020443-8A23E90D-8084-493A-BB4D-114C0612B316
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35020443-8A23E90D-8084-493A-BB4D-114C0612B316
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9f2986666d395a491d8b35f8df154c414eb34a7b
P2860
Quantitative ER and PgR assessment as predictors of benefit from lapatinib in postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer.